Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q2

4502.TEDINET S100PFY3
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥1.97T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.00T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.79T2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥844.8bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥255.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥104.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥346.0bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥97.4bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥220.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥64.5bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥284.4bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥61.4bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥183.6bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥46.0bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥183.7bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥46.0bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥14.59Tat 2022-09-30Cons.Assets IFRS
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.56Tat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.88Tat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥6.71Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.32Tat 2021-09-30Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥6.71Tat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥798.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥607.9bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥305.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥400.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥121.9bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥103.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥267.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥658.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥107.622022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥39.772022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥117.082021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥29.242021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥106.882022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥39.482022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥116.42021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥29.082021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio46.0%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio42.4%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 750
ItemContextValueUnit
Selling general and administrative expenses IFRSCurrentQuarterDuration248734000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration131600000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration154145000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSPrior1QuarterDuration102721000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSCurrentQuarterDuration142366000000JPY
Other operating income IFRSPrior1QuarterDuration8417000000JPY
Other operating income IFRSCurrentQuarterDuration7997000000JPY
Other operating expenses IFRSPrior1QuarterDuration33680000000JPY
Other operating expenses IFRSCurrentQuarterDuration55177000000JPY
Operating profit loss IFRSPrior1QuarterDuration97427000000JPY
Operating profit loss IFRSCurrentQuarterDuration104438000000JPY
Finance income IFRSPrior1QuarterDuration6864000000JPY
Finance income IFRSCurrentQuarterDuration14782000000JPY
Finance costs IFRSPrior1QuarterDuration39676000000JPY
Finance costs IFRSCurrentQuarterDuration53803000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration-3168000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration-869000000JPY
Profit loss before tax IFRSPrior1QuarterDuration61447000000JPY
Profit loss before tax IFRSCurrentQuarterDuration64549000000JPY
Income tax expense IFRSPrior1QuarterDuration15452000000JPY
Income tax expense IFRSCurrentQuarterDuration2817000000JPY
Profit loss IFRSPrior1QuarterDuration45994000000JPY
Profit loss IFRSCurrentQuarterDuration61732000000JPY
Profit loss attributable to owners of parent IFRSPrior1QuarterDuration45964000000JPY
Profit loss attributable to owners of parent IFRSCurrentQuarterDuration61742000000JPY
Profit loss attributable to non controlling interests IFRSPrior1QuarterDuration31000000JPY
Profit loss attributable to non controlling interests IFRSCurrentQuarterDuration-10000000JPY
Profit loss IFRSPrior1QuarterDuration45994000000JPY
Profit loss IFRSCurrentQuarterDuration61732000000JPY
Basic earnings loss per share IFRSPrior1QuarterDuration29.24
Basic earnings loss per share IFRSCurrentQuarterDuration39.77
Diluted earnings loss per share IFRSPrior1QuarterDuration29.08
Diluted earnings loss per share IFRSCurrentQuarterDuration39.48
Profit loss IFRSPrior1YTDDuration183721000000JPY
Profit loss IFRSCurrentYTDDuration166753000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration4269000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration5284000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-1702000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration13395000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration2568000000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration18679000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration66700000000JPY
Exchange differences on translation of foreign operations net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration1035192000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration11553000000JPY
Effective portion of cash flow hedges net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-33200000000JPY
Hedging cost net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration5785000000JPY
Hedging cost net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-22749000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration-37000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that may be reclassified to profit or loss oci IFRSCurrentYTDDuration-1085000000JPY
Total of items that may be reclassified to profit or loss oci IFRSPrior1YTDDuration84000000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass